PENICILLIN G BENZATHINE

PENICILLIN G BENZATHINE was reported 1363 times

PENICILLIN G BENZATHINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEONATAL GASTROINTESTINAL DISORDER 11 0.4074
1 CUTANEOUS ANTHRAX 1 0.2000
2 PENICILLIUM TEST POSITIVE 1 0.2000
3 NEONATAL HYPERGLYCAEMIA 6 0.1622
4 CRYOFIBRINOGENAEMIA 1 0.1250
5 CONGENITAL SYPHILIS 6 0.1132
6 INTRACRANIAL HAEMORRHAGE NEONATAL 1 0.0769
7 MEDIASTINAL ABSCESS 8 0.0615
8 RECALLED PRODUCT ADMINISTERED 573 0.0600
9 EMBOLIA CUTIS MEDICAMENTOSA 44 0.0553
10 PAEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDERS ASSOCIATED WITH STREPTOCOCCAL INFECTION 1 0.0385
11 WOUND CONTAMINATION 1 0.0333
12 NEONATAL RESPIRATORY DEPRESSION 11 0.0331
13 ILEAL ULCER PERFORATION 1 0.0323
14 FOETAL HEART RATE DISORDER 6 0.0311
15 SECONDARY SYPHILIS 3 0.0303
16 BLOOD ALCOHOL ABNORMAL 1 0.0303
17 CHRONIC RHINOSINUSITIS WITH NASAL POLYPS 4 0.0270
18 JARISCH-HERXHEIMER REACTION 18 0.0253
19 DUODENAL ATRESIA 3 0.0244
20 HEPATOSPLENOMEGALY NEONATAL 1 0.0238
21 PHALANGEAL AGENESIS 1 0.0192
22 SYPHILIS 13 0.0179
23 PENILE DERMATITIS 1 0.0159
24 BARTONELLOSIS 1 0.0152
25 CULTURE STOOL POSITIVE 4 0.0146
26 MUSCLE FIBROSIS 1 0.0137
27 KERATOSIS FOLLICULAR 1 0.0128
28 XANTHOGRANULOMA 1 0.0125
29 LIVIDITY 4 0.0109
30 SEGMENTED HYALINISING VASCULITIS 1 0.0098
31 PROPHYLAXIS AGAINST TRANSPLANT REJECTION 1 0.0097
32 ACQUIRED FACTOR V DEFICIENCY 1 0.0091
33 RHEUMATIC HEART DISEASE 1 0.0088
34 BLADDER DISCOMFORT 11 0.0088
35 SPINE MALFORMATION 3 0.0086
36 BACTERIAL TOXAEMIA 1 0.0078
37 VESSEL PERFORATION 1 0.0076
38 ANAL ATRESIA 4 0.0075
39 HYPERADRENOCORTICISM 2 0.0073
40 CANDIDA TEST POSITIVE 3 0.0072
41 URTICARIA CHRONIC 4 0.0071
42 TRICHOMONIASIS 1 0.0069
43 EXTRAPULMONARY TUBERCULOSIS 2 0.0068
44 NEUROSYPHILIS 1 0.0066
45 NAEVUS FLAMMEUS 1 0.0064
46 PHARYNGEAL NEOPLASM 1 0.0064
47 KLEBSIELLA BACTERAEMIA 6 0.0063
48 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 2 0.0060
49 OBSTRUCTED LABOUR 1 0.0059
50 PULMONARY NECROSIS 2 0.0059
51 VACCINATION SITE SWELLING 1 0.0058
52 DRUG RESISTANCE MUTATION 1 0.0056
53 IMMUNE-MEDIATED UVEITIS 1 0.0055
54 ENANTHEMA 3 0.0052
55 ARTERIAL SPASM 1 0.0051
56 STRONGYLOIDIASIS 8 0.0049
57 GLOMERULONEPHRITIS ACUTE 1 0.0049
58 OESOPHAGEAL ATRESIA 3 0.0048
59 VACCINATION SITE ERYTHEMA 1 0.0046
60 HISTOLOGY ABNORMAL 1 0.0045
61 OLIGODIPSIA 1 0.0043
62 SJS-TEN OVERLAP 3 0.0043
63 CEREBROVASCULAR INSUFFICIENCY 1 0.0041
64 FEMALE STERILISATION 2 0.0039
65 EXPOSURE TO CONTAMINATED DEVICE 1 0.0038
66 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 1 0.0036
67 BACTERIURIA 2 0.0035
68 PALMAR ERYTHEMA 4 0.0035
69 PYOMYOSITIS 1 0.0034
70 RELAPSING MULTIPLE SCLEROSIS 1 0.0033
71 BUTTOCK INJURY 1 0.0033
72 ERYTHROPOIESIS ABNORMAL 1 0.0033
73 INJECTION SITE CELLULITIS 6 0.0032
74 THERAPEUTIC EMBOLISATION 1 0.0032
75 PENILE ULCERATION 1 0.0031
76 VULVOVAGINAL CANDIDIASIS 4 0.0030
77 INJECTION SITE ABSCESS 7 0.0028
78 DRUG-GENETIC INTERACTION 1 0.0028
79 MILIA 1 0.0028
80 HYDROURETER 1 0.0026
81 BONE TUBERCULOSIS 1 0.0026
82 LIMB AMPUTATION 1 0.0025
83 THROMBOCYTOPENIA NEONATAL 1 0.0024
84 GLIOSIS 1 0.0023
85 INFLUENZA A VIRUS TEST POSITIVE 1 0.0023
86 FOETAL GROWTH RESTRICTION 14 0.0023
87 COMPARTMENT SYNDROME 6 0.0023
88 HIP DEFORMITY 1 0.0023
89 EXPIRED DRUG ADMINISTERED 11 0.0022
90 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 2 0.0022
91 ANAEMIA NEONATAL 1 0.0021
92 EAR INJURY 1 0.0020
93 DERMATITIS INFECTED 1 0.0020
94 RETINOPATHY OF PREMATURITY 1 0.0018
95 CHOLESTATIC LIVER INJURY 4 0.0018
96 FEMALE GENITAL TRACT FISTULA 3 0.0018
97 VACCINATION SITE PAIN 1 0.0017
98 ADMINISTRATION SITE PAIN 2 0.0017
99 LIMB REDUCTION DEFECT 1 0.0017
100 PROCALCITONIN INCREASED 2 0.0017
101 CRYSTAL NEPHROPATHY 1 0.0017
102 TOXIC SHOCK SYNDROME 1 0.0016
103 PNEUMONIA NECROTISING 1 0.0015
104 MYELITIS TRANSVERSE 2 0.0014
105 PUBIS FRACTURE 1 0.0014
106 ACCOMMODATION DISORDER 1 0.0014
107 HEART SOUNDS ABNORMAL 1 0.0013
108 CHLAMYDIAL INFECTION 1 0.0013
109 TINEA PEDIS 2 0.0013
110 INFANTILE APNOEA 1 0.0012
111 BRADYCARDIA FOETAL 1 0.0012
112 LYME DISEASE 4 0.0012
113 INJECTION SITE OEDEMA 2 0.0012
114 INCORRECT STORAGE OF DRUG 2 0.0012
115 UPPER AIRWAY OBSTRUCTION 1 0.0011
116 ANOGENITAL WARTS 1 0.0011
117 MUSCLE NECROSIS 1 0.0011
118 ULCERATIVE KERATITIS 3 0.0011
119 COLOUR BLINDNESS 1 0.0011
120 MUSCLE SWELLING 1 0.0011
121 PRODUCT APPEARANCE CONFUSION 1 0.0011
122 MACULE 3 0.0011
123 DELAYED RECOVERY FROM ANAESTHESIA 1 0.0011
124 INJECTION SITE SCAR 3 0.0011
125 HYPOCOAGULABLE STATE 1 0.0010
126 MASTOIDITIS 1 0.0010
127 HYPERAEMIA 2 0.0010
128 DEVICE SAFETY FEATURE ISSUE 1 0.0010
129 ODYNOPHAGIA 6 0.0010
130 ACQUIRED HAEMOPHILIA 1 0.0010
131 HIV INFECTION 3 0.0010
132 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
133 HYPOCHROMIC ANAEMIA 1 0.0010
134 REDUCED FACIAL EXPRESSION 1 0.0010
135 MUSCLE CONTRACTURE 2 0.0010
136 BREAST ABSCESS 1 0.0010
137 POLYHYDRAMNIOS 1 0.0010
138 AXILLARY MASS 1 0.0010
139 BONE DEMINERALISATION 1 0.0009
140 SYRINGE ISSUE 16 0.0009
141 PNEUMONIA STREPTOCOCCAL 1 0.0009
142 PERIRECTAL ABSCESS 1 0.0009
143 MENINGITIS ASEPTIC 4 0.0009
144 BLOODY DISCHARGE 1 0.0009
145 ECCHYMOSIS 6 0.0009
146 PRODUCT CONTAMINATION 3 0.0008
147 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
148 ERYSIPELAS 4 0.0008
149 VULVOVAGINAL PRURITUS 4 0.0008
150 INCREASED BRONCHIAL SECRETION 2 0.0008
151 SKIN NECROSIS 4 0.0008
152 HYPERSENSITIVITY VASCULITIS 2 0.0008
153 FEELING GUILTY 1 0.0008
154 CALCULUS BLADDER 1 0.0007
155 BILIARY TRACT DISORDER 1 0.0007
156 SERUM SICKNESS 2 0.0007
157 PERIPHERAL ARTERY THROMBOSIS 1 0.0007
158 LIP OEDEMA 3 0.0007
159 CATAPLEXY 1 0.0007
160 TONIC CONVULSION 1 0.0007
161 GLUTEN SENSITIVITY 1 0.0007
162 CEREBELLAR HAEMORRHAGE 1 0.0007
163 DYSPNOEA AT REST 2 0.0007
164 HAEMOTHORAX 2 0.0007
165 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
166 NORMOCYTIC ANAEMIA 1 0.0007
167 TRANSFUSION 7 0.0007
168 PREMATURE BABY 20 0.0007
169 HYPERCAPNIA 2 0.0007
170 CALCULUS URINARY 1 0.0006
171 NEURITIS 1 0.0006
172 HISTOPLASMOSIS DISSEMINATED 1 0.0006
173 STILLBIRTH 3 0.0006
174 RESPIRATORY ALKALOSIS 1 0.0006
175 INJECTION RELATED REACTION 1 0.0006
176 LINEAR IGA DISEASE 1 0.0006
177 OLIGOHYDRAMNIOS 2 0.0006
178 TONSILLAR HYPERTROPHY 1 0.0006
179 TOXIC ENCEPHALOPATHY 3 0.0006
180 HEPATIC FIBROSIS 2 0.0006
181 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
182 POOR QUALITY PRODUCT ADMINISTERED 6 0.0006
183 NECROTISING FASCIITIS 2 0.0006
184 MITRAL VALVE DISEASE 1 0.0006
185 INDURATION 1 0.0006
186 OBSESSIVE THOUGHTS 1 0.0006
187 INJECTION SITE NODULE 6 0.0005
188 OESOPHAGEAL SPASM 1 0.0005
189 ECONOMIC PROBLEM 8 0.0005
190 NEUROLOGICAL SYMPTOM 3 0.0005
191 OSTEOPOROTIC FRACTURE 1 0.0005
192 CLEFT PALATE 1 0.0005
193 WOUND SECRETION 2 0.0005
194 BICYTOPENIA 1 0.0005
195 UNDERWEIGHT 1 0.0005
196 OESOPHAGEAL PAIN 2 0.0005
197 ANORECTAL DISORDER 1 0.0005
198 FUNGAL SKIN INFECTION 2 0.0005
199 RASH MACULO-PAPULAR 11 0.0005
200 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
201 INJECTION SITE NECROSIS 1 0.0005
202 TONGUE BITING 1 0.0005
203 HYPOSPADIAS 1 0.0005
204 PHARYNGEAL ERYTHEMA 1 0.0005
205 FOETAL DISTRESS SYNDROME 1 0.0005
206 HYPERPHOSPHATAEMIA 1 0.0005
207 POOR QUALITY DRUG ADMINISTERED 3 0.0005
208 DYSPHEMIA 2 0.0005
209 CORNEAL DISORDER 1 0.0005
210 PARESIS 1 0.0004
211 RHEUMATIC FEVER 2 0.0004
212 PSEUDOMEMBRANOUS COLITIS 1 0.0004
213 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 1 0.0004
214 NEEDLE ISSUE 13 0.0004
215 PRODUCT LABEL ISSUE 3 0.0004
216 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
217 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
218 PULSE ABSENT 2 0.0004
219 SUBCUTANEOUS ABSCESS 2 0.0004
220 PREMATURE RUPTURE OF MEMBRANES 1 0.0004
221 SELF ESTEEM DECREASED 1 0.0004
222 HAEMATOLOGICAL INFECTION 1 0.0004
223 COELIAC DISEASE 4 0.0004
224 EYE OEDEMA 1 0.0004
225 PENIS DISORDER 1 0.0004
226 CATHETER SITE HAEMORRHAGE 1 0.0004
227 POOR QUALITY DEVICE USED 4 0.0004
228 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
229 ANGLE CLOSURE GLAUCOMA 1 0.0004
230 HEPATOSPLENOMEGALY 1 0.0004
231 AORTIC ARTERIOSCLEROSIS 1 0.0004
232 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
233 PETECHIAE 4 0.0004
234 PARTIAL SEIZURES 2 0.0004
235 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
236 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
237 SERUM FERRITIN INCREASED 2 0.0004
238 AGRANULOCYTOSIS 7 0.0004
239 AREFLEXIA 1 0.0004
240 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
241 OVERWEIGHT 2 0.0004
242 RHINALGIA 1 0.0004
243 RASH MORBILLIFORM 1 0.0004
244 NECROSIS 2 0.0004
245 LIVE BIRTH 3 0.0004
246 SKIN HYPERTROPHY 1 0.0004
247 SKIN PLAQUE 3 0.0004
248 ATYPICAL FEMUR FRACTURE 1 0.0004
249 STATUS EPILEPTICUS 4 0.0004
250 RESPIRATORY SYMPTOM 1 0.0004
251 DERMATITIS CONTACT 4 0.0004
252 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
253 PARAPLEGIA 1 0.0003
254 ENTEROCOLITIS 2 0.0003
255 METABOLIC DISORDER 2 0.0003
256 ABORTION 1 0.0003
257 ANHEDONIA 9 0.0003
258 INJECTION SITE WARMTH 7 0.0003
259 RESPIRATORY RATE INCREASED 3 0.0003
260 HEPATITIS FULMINANT 1 0.0003
261 BLOOD CULTURE POSITIVE 1 0.0003
262 GANGRENE 2 0.0003
263 CEREBROVASCULAR DISORDER 1 0.0003
264 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
265 DUODENITIS 1 0.0003
266 ECTOPIC PREGNANCY 1 0.0003
267 TESTICULAR PAIN 1 0.0003
268 STEVENS-JOHNSON SYNDROME 7 0.0003
269 CUSHINGOID 1 0.0003
270 STUPOR 1 0.0003
271 INJECTION SITE INDURATION 4 0.0003
272 INJECTION SITE INFECTION 1 0.0003
273 ORAL CANDIDIASIS 4 0.0003
274 IMMUNE SYSTEM DISORDER 4 0.0003
275 INJECTION SITE SWELLING 23 0.0003
276 INJURY ASSOCIATED WITH DEVICE 6 0.0003
277 BRONCHOPNEUMONIA 1 0.0003
278 SKIN LESION 8 0.0003
279 PERIPHERAL COLDNESS 4 0.0003
280 MICTURITION DISORDER 1 0.0003
281 HANGOVER 1 0.0003
282 PAPULE 2 0.0003
283 NEONATAL RESPIRATORY DISTRESS SYNDROME 1 0.0003
284 SKIN WEEPING 1 0.0003
285 APPARENT DEATH 1 0.0003
286 INJECTION SITE HAEMATOMA 4 0.0003
287 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
288 DYSSTASIA 8 0.0003
289 ASTHMATIC CRISIS 1 0.0003
290 THROMBOCYTOSIS 1 0.0003
291 VIRAL MUTATION IDENTIFIED 1 0.0003
292 DEVICE BREAKAGE 11 0.0003
293 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
294 HYPERACUSIS 1 0.0003
295 FOETAL EXPOSURE DURING PREGNANCY 21 0.0003
296 PANIC DISORDER 1 0.0003
297 CAESAREAN SECTION 3 0.0003
298 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
299 PALLOR 7 0.0003
300 APNOEA 2 0.0003
301 VENOUS THROMBOSIS 1 0.0003
302 CYANOSIS 4 0.0003
303 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
304 PATENT DUCTUS ARTERIOSUS 1 0.0003
305 RENAL CYST 2 0.0003
306 MYOCLONUS 3 0.0003
307 EXPOSURE VIA BREAST MILK 1 0.0003
308 SKIN PAPILLOMA 1 0.0002
309 CYSTITIS HAEMORRHAGIC 1 0.0002
310 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
311 ASPHYXIA 2 0.0002
312 PERIPHERAL ISCHAEMIA 1 0.0002
313 PHARYNGITIS 3 0.0002
314 INJECTION SITE DISCOLOURATION 3 0.0002
315 ANAPHYLACTIC REACTION 13 0.0002
316 ABSCESS LIMB 1 0.0002
317 PURULENT DISCHARGE 1 0.0002
318 MONOPLEGIA 1 0.0002
319 INCORRECT PRODUCT STORAGE 3 0.0002
320 GROIN PAIN 2 0.0002
321 DRUG ERUPTION 4 0.0002
322 MYOSITIS 2 0.0002
323 IRON DEFICIENCY 1 0.0002
324 URINARY TRACT DISORDER 1 0.0002
325 SUSPECTED OFF LABEL USE 1 0.0002
326 LEUKOCYTOSIS 4 0.0002
327 ABDOMINAL HERNIA 1 0.0002
328 EAR DISORDER 1 0.0002
329 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
330 INJECTION SITE MASS 8 0.0002
331 CONJUNCTIVITIS 4 0.0002
332 PREGNANCY WITH IMPLANT CONTRACEPTIVE 1 0.0002
333 PRODUCT PACKAGING ISSUE 2 0.0002
334 PRE-ECLAMPSIA 1 0.0002
335 INJECTION SITE PAIN 63 0.0002
336 INCORRECT DOSAGE ADMINISTERED 1 0.0002
337 ACUTE KIDNEY INJURY 31 0.0002
338 MATERNAL EXPOSURE DURING PREGNANCY 18 0.0002
339 INABILITY TO AFFORD MEDICATION 2 0.0002
340 ABDOMINAL TENDERNESS 1 0.0002
341 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
342 OSTEOPENIA 3 0.0002
343 DRUG RESISTANCE 5 0.0002
344 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
345 FOETAL DEATH 1 0.0002
346 TENDERNESS 2 0.0002
347 RHABDOMYOLYSIS 8 0.0002
348 BONE DENSITY DECREASED 6 0.0002
349 INJECTION SITE DISCOMFORT 2 0.0002
350 ANAL FISTULA 1 0.0002
351 COMPRESSION FRACTURE 1 0.0002
352 INJECTION SITE DISCHARGE 1 0.0002
353 ANAL ABSCESS 1 0.0002
354 SKIN LACERATION 2 0.0002
355 TIC 1 0.0002
356 TRANSAMINASES INCREASED 4 0.0002
357 STREPTOCOCCAL INFECTION 1 0.0002
358 INTRACRANIAL PRESSURE INCREASED 1 0.0002
359 ANGIOPATHY 1 0.0002
360 ACUTE PULMONARY OEDEMA 1 0.0002
361 EXPOSURE DURING PREGNANCY 11 0.0002
362 PREMATURE LABOUR 1 0.0002
363 CIRCULATORY COLLAPSE 3 0.0002
364 VENTRICULAR SEPTAL DEFECT 1 0.0002
365 HYPERTONIA 1 0.0002
366 BLOOD URIC ACID INCREASED 1 0.0002
367 HYPERVENTILATION 1 0.0002
368 SKIN WARM 1 0.0002
369 PRODUCT LABEL CONFUSION 1 0.0002
370 URINE ODOUR ABNORMAL 1 0.0002
371 INJECTION SITE VESICLES 1 0.0002
372 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3 0.0002
373 DRUG ADMINISTRATION ERROR 5 0.0002
374 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
375 ABASIA 4 0.0002
376 DRUG-INDUCED LIVER INJURY 5 0.0002
377 BLEPHAROSPASM 1 0.0002
378 SCREAMING 1 0.0002
379 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
380 ANAPHYLACTIC SHOCK 4 0.0002
381 INFLAMMATION 8 0.0002
382 TENDON DISORDER 1 0.0002
383 NODULE 2 0.0002
384 PRODUCT PREPARATION ISSUE 1 0.0002
385 PULMONARY CONGESTION 2 0.0002
386 PRODUCT FORMULATION ISSUE 1 0.0002
387 JAUNDICE 4 0.0001
388 WRONG PRODUCT ADMINISTERED 1 0.0001
389 UVEITIS 2 0.0001
390 TACHYPNOEA 2 0.0001
391 DEVICE DELIVERY SYSTEM ISSUE 4 0.0001
392 HAEMATURIA 5 0.0001
393 HOT FLUSH 11 0.0001
394 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
395 RESPIRATORY DISTRESS 4 0.0001
396 TOOTH LOSS 3 0.0001
397 LYMPHOEDEMA 1 0.0001
398 AUTOIMMUNE HEPATITIS 1 0.0001
399 MASS 2 0.0001
400 PULMONARY TOXICITY 1 0.0001
401 HAND FRACTURE 1 0.0001
402 THERMAL BURN 1 0.0001
403 LEUKOPENIA 7 0.0001
404 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
405 NO ADVERSE EVENT 25 0.0001
406 MEDICAL DEVICE COMPLICATION 1 0.0001
407 CEREBRAL DISORDER 1 0.0001
408 HYDRONEPHROSIS 1 0.0001
409 PANCREATITIS 7 0.0001
410 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
411 SKIN DISCOLOURATION 6 0.0001
412 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
413 ATRIOVENTRICULAR BLOCK 1 0.0001
414 TENDONITIS 2 0.0001
415 HYPOALBUMINAEMIA 1 0.0001
416 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
417 FURUNCLE 1 0.0001
418 DISEASE RECURRENCE 6 0.0001
419 PNEUMOTHORAX 2 0.0001
420 PREMATURE DELIVERY 2 0.0001
421 TRANSPLANT REJECTION 1 0.0001
422 HYPONATRAEMIA 7 0.0001
423 SENSORY LOSS 1 0.0001
424 MUSCLE INJURY 1 0.0001
425 COAGULOPATHY 2 0.0001
426 ATRIAL SEPTAL DEFECT 1 0.0001
427 SKIN HYPERPIGMENTATION 1 0.0001
428 ANURIA 1 0.0001
429 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
430 RASH MACULAR 4 0.0001
431 URINE OUTPUT DECREASED 1 0.0001
432 TUMOUR LYSIS SYNDROME 1 0.0001
433 HYPOXIA 4 0.0001
434 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
435 LYMPHADENOPATHY 4 0.0001
436 INJECTION SITE ERYTHEMA 14 0.0001
437 WRONG DRUG ADMINISTERED 1 0.0001
438 HAEMARTHROSIS 1 0.0001
439 DEVELOPMENTAL DELAY 1 0.0001
440 OROPHARYNGEAL DISCOMFORT 1 0.0001
441 OEDEMA 6 0.0001
442 OPTIC NEURITIS 1 0.0001
443 PATHOGEN RESISTANCE 1 0.0001
444 HIDRADENITIS 1 0.0001
445 SKIN IRRITATION 5 0.0001
446 RESPIRATORY ARREST 3 0.0001
447 MEDICATION ERROR 6 0.0001
448 FEELING COLD 3 0.0001
449 HYPERSENSITIVITY 20 0.0001
450 NEPHROPATHY 1 0.0001
451 PHOTOPHOBIA 2 0.0001
452 ASTHMA 12 0.0001
453 FOOT FRACTURE 2 0.0001
454 SPUTUM DISCOLOURED 1 0.0001
455 SLEEP APNOEA SYNDROME 2 0.0001
456 CHOLESTASIS 2 0.0001
457 AFFECT LABILITY 1 0.0001
458 PRESCRIBED OVERDOSE 2 0.0001
459 LIVER FUNCTION TEST ABNORMAL 3 0.0001
460 LOSS OF CONSCIOUSNESS 13 0.0001
461 LIGAMENT SPRAIN 1 0.0001
462 HYPOTONIA 1 0.0001
463 SLUGGISHNESS 1 0.0001
464 BODY TEMPERATURE INCREASED 2 0.0001
465 EAR DISCOMFORT 1 0.0001
466 UNINTENDED PREGNANCY 1 0.0001
467 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
468 JOINT DISLOCATION 1 0.0001
469 RENAL FAILURE ACUTE 4 0.0001
470 METABOLIC ACIDOSIS 3 0.0001
471 BODY HEIGHT DECREASED 1 0.0001
472 PHARYNGITIS STREPTOCOCCAL 1 0.0001
473 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
474 MENSTRUATION DELAYED 1 0.0001
475 PRODUCT DISPENSING ERROR 2 0.0001
476 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
477 EMOTIONAL DISTRESS 11 0.0001
478 TOOTH FRACTURE 1 0.0001
479 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
480 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
481 SKIN DISORDER 3 0.0001
482 NERVE INJURY 1 0.0001
483 SKIN INFECTION 1 0.0001
484 NEPHROPATHY TOXIC 1 0.0001
485 FISTULA 1 0.0001
486 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16 0.0001
487 EYE INFECTION 1 0.0001
488 ERYTHEMA 18 0.0001
489 GASTRIC DISORDER 3 0.0001
490 TINNITUS 4 0.0001
491 MUSCLE TWITCHING 2 0.0001
492 CHEST PAIN 16 0.0001
493 HYPERHIDROSIS 11 0.0001
494 SPLENOMEGALY 1 0.0001
495 BLOOD PRESSURE INCREASED 13 0.0001
496 HOSPITALISATION 13 0.0001
497 TREATMENT FAILURE 7 0.0001
498 MUSCLE RIGIDITY 1 0.0001
499 URTICARIA 14 0.0001
500 LOCALISED INFECTION 2 0.0001
501 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
502 NEURALGIA 2 0.0001
503 URINARY TRACT INFECTION 14 0.0001
504 DISCOMFORT 5 0.0001
505 CEREBRAL INFARCTION 2 0.0001
506 FEELING HOT 5 0.0001
507 INJECTION SITE EXTRAVASATION 1 0.0001
508 TENDON RUPTURE 1 0.0001
509 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
510 ILEUS 1 0.0001
511 SYNCOPE 8 0.0001
512 CELLULITIS 4 0.0001
513 BRAIN OEDEMA 1 0.0001
514 CHRONIC KIDNEY DISEASE 6 0.0001
515 HAEMATEMESIS 2 0.0001
516 HEPATIC CYTOLYSIS 1 0.0001
517 DEVICE DEPLOYMENT ISSUE 1 0.0001
518 SEIZURE 9 0.0001
519 ANOREXIA 1 0.0001
520 GASTRITIS 2 0.0001
521 ADVERSE REACTION 1 0.0001
522 INJECTION SITE HAEMORRHAGE 6 0.0001
523 THROAT TIGHTNESS 2 0.0001
524 LIMB INJURY 2 0.0001
525 DRUG TOXICITY 1 0.0001
526 OSTEOPOROSIS 3 0.0001
527 CARDIAC ARREST 6 0.0001
528 POLLAKIURIA 3 0.0001
529 CARDIO-RESPIRATORY ARREST 3 0.0001
530 WOUND 2 0.0001
531 BLISTER 4 0.0001
532 DEVICE OCCLUSION 1 0.0001
533 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
534 SEASONAL ALLERGY 1 0.0001
535 DIALYSIS 1 0.0001
536 PAIN 43 0.0001
537 CONVULSION 4 0.0001
538 PARALYSIS 1 0.0001
539 ACCIDENTAL UNDERDOSE 1 0.0001
540 HYPERTHYROIDISM 1 0.0001
541 SEPTIC SHOCK 3 0.0001
542 HYPOKINESIA 1 0.0001
543 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
544 URINARY INCONTINENCE 2 0.0001
545 PULMONARY MASS 1 0.0001
546 PYREXIA 23 0.0001
547 DEVICE FAILURE 1 0.0001
548 DRUG DISPENSING ERROR 1 0.0001
549 EPILEPSY 2 0.0001
550 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
551 DEVICE RELATED INFECTION 1 0.0001
552 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
553 PRODUCT USE IN UNAPPROVED INDICATION 16 0.0001
554 RASH 28 0.0001
555 SWOLLEN TONGUE 2 0.0001
556 PRODUCT USE COMPLAINT 1 0.0001
557 OCULAR HYPERAEMIA 3 0.0001
558 DYSPHAGIA 6 0.0001
559 HALLUCINATION, AUDITORY 1 0.0001
560 SCIATICA 1 0.0001
561 ABSCESS 1 0.0001
562 SENSORY DISTURBANCE 1 0.0001
563 INTERSTITIAL LUNG DISEASE 3 0.0001
564 MUSCLE TIGHTNESS 1 0.0001
565 STAPHYLOCOCCAL INFECTION 2 0.0001
566 PHOTOSENSITIVITY REACTION 1 0.0001
567 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
568 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
569 HYPOAESTHESIA 9 0.0001
570 GAIT INABILITY 2 0.0001
571 FACE OEDEMA 1 0.0001
572 SKIN EXFOLIATION 5 0.0001
573 CANDIDA INFECTION 1 0.0001
574 METRORRHAGIA 1 0.0001
575 HAEMOGLOBIN DECREASED 6 0.0001
576 SCAR 1 0.0001
577 PARANOIA 1 0.0001
578 MULTI-ORGAN FAILURE 1 0.0001
579 DEVICE DEFECTIVE 1 0.0001
580 DEVICE USE ERROR 2 0.0001
581 GAIT DISTURBANCE 11 0.0001
582 EOSINOPHILIA 1 0.0001
583 BURNING SENSATION 4 0.0001
584 HYPERKALAEMIA 2 0.0001
585 HEART RATE DECREASED 2 0.0001
586 COLD SWEAT 1 0.0001
587 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
588 ANXIETY 16 0.0001
589 GALLBLADDER DISORDER 1 0.0001
590 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
591 SYNOVITIS 1 0.0001
592 CRYING 2 0.0001
593 C-REACTIVE PROTEIN INCREASED 2 0.0001
594 BONE DISORDER 1 0.0001
595 PANIC ATTACK 2 0.0001
596 ACCIDENTAL OVERDOSE 2 0.0001
597 NASOPHARYNGITIS 10 0.0001
598 TREMOR 9 0.0001
599 THINKING ABNORMAL 1 0.0001
600 OXYGEN SATURATION DECREASED 3 0.0001
601 HYPOCALCAEMIA 1 0.0001
602 GASTRIC ULCER 1 0.0001
603 INCORRECT DOSE ADMINISTERED 12 0.0001
604 FEELING JITTERY 1 0.0001
605 POST PROCEDURAL COMPLICATION 1 0.0001
606 DYSTONIA 1 0.0001
607 EAR PAIN 1 0.0001
608 OFF LABEL USE 45 0.0001
609 CHILLS 6 0.0001
610 SKIN FISSURES 1 0.0001
611 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
612 HEART RATE INCREASED 5 0.0001
613 HAEMATOCRIT DECREASED 1 0.0001
614 UPPER LIMB FRACTURE 1 0.0001
615 CARDIAC FAILURE 4 0.0000
616 INTENTIONAL SELF-INJURY 1 0.0000
617 PRODUCT ADMINISTRATION ERROR 1 0.0000
618 STOMATITIS 3 0.0000
619 PLEURAL EFFUSION 3 0.0000
620 DYSKINESIA 2 0.0000
621 PRODUCT PREPARATION ERROR 1 0.0000
622 PRODUCT USE ISSUE 9 0.0000
623 DERMATITIS 1 0.0000
624 RENAL IMPAIRMENT 4 0.0000
625 HALLUCINATION, VISUAL 1 0.0000
626 ABDOMINAL PAIN 11 0.0000
627 IMPAIRED WORK ABILITY 1 0.0000
628 DEVICE LEAKAGE 2 0.0000
629 BLOOD CREATININE INCREASED 3 0.0000
630 PRODUCT STORAGE ERROR 4 0.0000
631 MUSCULOSKELETAL STIFFNESS 4 0.0000
632 FEBRILE NEUTROPENIA 3 0.0000
633 RENAL FAILURE 6 0.0000
634 LIVER DISORDER 2 0.0000
635 HEPATOTOXICITY 1 0.0000
636 GLOSSODYNIA 1 0.0000
637 THROAT IRRITATION 2 0.0000
638 PANCREATITIS ACUTE 1 0.0000
639 CHROMATURIA 1 0.0000
640 HEART RATE IRREGULAR 1 0.0000
641 HEPATIC ENZYME INCREASED 3 0.0000
642 INJECTION SITE REACTION 3 0.0000
643 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
644 COGNITIVE DISORDER 2 0.0000
645 SWELLING 4 0.0000
646 PALPITATIONS 5 0.0000
647 PRODUCT PRESCRIBING ERROR 1 0.0000
648 PRODUCTIVE COUGH 2 0.0000
649 RASH ERYTHEMATOUS 2 0.0000
650 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
651 INFECTION 6 0.0000
652 DRUG INTOLERANCE 4 0.0000
653 RESPIRATORY FAILURE 3 0.0000
654 FIBROMYALGIA 1 0.0000
655 PRESYNCOPE 1 0.0000
656 UNDERDOSE 3 0.0000
657 OEDEMA PERIPHERAL 5 0.0000
658 AGITATION 3 0.0000
659 LUNG DISORDER 2 0.0000
660 ENCEPHALOPATHY 1 0.0000
661 DIARRHOEA 26 0.0000
662 HALLUCINATION 3 0.0000
663 PRODUCT COMPLAINT 1 0.0000
664 FLUID RETENTION 2 0.0000
665 ILLNESS 4 0.0000
666 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
667 UNRESPONSIVE TO STIMULI 1 0.0000
668 HAEMATOMA 1 0.0000
669 EXPOSURE VIA SKIN CONTACT 1 0.0000
670 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
671 DIPLOPIA 1 0.0000
672 RESPIRATORY TRACT INFECTION 1 0.0000
673 PSORIASIS 5 0.0000
674 HEADACHE 24 0.0000
675 NERVOUSNESS 2 0.0000
676 HAEMORRHAGE 4 0.0000
677 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
678 PARAESTHESIA 6 0.0000
679 DIZZINESS 19 0.0000
680 DEPRESSED MOOD 2 0.0000
681 DRUG INTERACTION 6 0.0000
682 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
683 FEELING ABNORMAL 9 0.0000
684 DEHYDRATION 5 0.0000
685 MENSTRUATION IRREGULAR 1 0.0000
686 PAIN IN EXTREMITY 11 0.0000
687 PAIN OF SKIN 1 0.0000
688 BLOOD BILIRUBIN INCREASED 1 0.0000
689 RASH PRURITIC 2 0.0000
690 PRODUCT QUALITY ISSUE 5 0.0000
691 NEUTROPENIA 5 0.0000
692 TREATMENT NONCOMPLIANCE 2 0.0000
693 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
694 INFLUENZA 4 0.0000
695 HAEMOPTYSIS 1 0.0000
696 PANCYTOPENIA 2 0.0000
697 MYALGIA 6 0.0000
698 INTENTIONAL DOSE OMISSION 1 0.0000
699 BACK PAIN 8 0.0000
700 INTENTIONAL PRODUCT MISUSE 3 0.0000
701 DYSPHONIA 2 0.0000
702 HEPATIC FAILURE 1 0.0000
703 APHASIA 1 0.0000
704 INJECTION SITE RASH 1 0.0000
705 FEMUR FRACTURE 1 0.0000
706 ASTHENIA 12 0.0000
707 VOMITING 15 0.0000
708 NEUROPATHY PERIPHERAL 3 0.0000
709 CYSTITIS 1 0.0000
710 ARTHRALGIA 13 0.0000
711 CONTUSION 3 0.0000
712 RHINORRHOEA 2 0.0000
713 SWELLING FACE 2 0.0000
714 CHOLELITHIASIS 1 0.0000
715 IMPAIRED HEALING 1 0.0000
716 EYE DISORDER 1 0.0000
717 BLOOD PRESSURE DECREASED 2 0.0000
718 LIP SWELLING 1 0.0000
719 URINARY RETENTION 1 0.0000
720 HYPOTENSION 6 0.0000
721 MALAISE 13 0.0000
722 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
723 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
724 DELIRIUM 1 0.0000
725 INJURY 2 0.0000
726 DYSPNOEA 16 0.0000
727 PNEUMONIA 9 0.0000
728 MYELOSUPPRESSION 1 0.0000
729 DYSURIA 1 0.0000
730 EPISTAXIS 2 0.0000
731 DYSARTHRIA 1 0.0000
732 ACNE 2 0.0000
733 ANAEMIA 5 0.0000
734 PRURITUS 10 0.0000
735 PERIPHERAL SWELLING 4 0.0000
736 INJECTION SITE BRUISING 2 0.0000
737 DRUG INEFFECTIVE 33 0.0000
738 ABORTION SPONTANEOUS 1 0.0000
739 VISUAL IMPAIRMENT 3 0.0000
740 ROAD TRAFFIC ACCIDENT 1 0.0000
741 WITHDRAWAL SYNDROME 1 0.0000
742 FATIGUE 18 0.0000
743 CONDITION AGGRAVATED 7 0.0000
744 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
745 COVID-19 4 0.0000
746 ANGIOEDEMA 1 0.0000
747 TACHYCARDIA 2 0.0000
748 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
749 DEVICE ISSUE 2 0.0000
750 VISION BLURRED 3 0.0000
751 NEPHROLITHIASIS 1 0.0000
752 OROPHARYNGEAL PAIN 2 0.0000
753 RENAL DISORDER 1 0.0000
754 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
755 COUGH 6 0.0000
756 ARRHYTHMIA 1 0.0000
757 ATRIAL FIBRILLATION 2 0.0000
758 NAUSEA 16 0.0000
759 FLUSHING 2 0.0000
760 ABDOMINAL PAIN UPPER 4 0.0000
761 MUSCULOSKELETAL PAIN 1 0.0000
762 SPEECH DISORDER 1 0.0000
763 DERMATITIS ATOPIC 1 0.0000
764 BRADYCARDIA 1 0.0000
765 ARTHROPATHY 1 0.0000
766 SEPSIS 2 0.0000
767 THROMBOCYTOPENIA 2 0.0000
768 MUSCULAR WEAKNESS 2 0.0000
769 DEPRESSION 4 0.0000
770 DEATH 15 0.0000
771 BONE PAIN 1 0.0000
772 SURGERY 1 0.0000
773 NASAL CONGESTION 1 0.0000
774 WHEEZING 1 0.0000
775 DEEP VEIN THROMBOSIS 1 0.0000
776 AMNESIA 1 0.0000
777 INJECTION SITE PRURITUS 1 0.0000
778 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
779 MEMORY IMPAIRMENT 2 0.0000
780 DEVICE MALFUNCTION 1 0.0000
781 HYPERTENSION 3 0.0000
782 THERAPY INTERRUPTED 1 0.0000
783 MOBILITY DECREASED 1 0.0000
784 BRONCHITIS 1 0.0000
785 DYSGEUSIA 1 0.0000
786 DIABETES MELLITUS 1 0.0000
787 DECREASED APPETITE 3 0.0000
788 ARTHRITIS 1 0.0000
789 CARDIAC FAILURE CONGESTIVE 1 0.0000
790 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
791 INFLUENZA LIKE ILLNESS 1 0.0000
792 DRUG DOSE OMISSION 2 0.0000
793 FALL 4 0.0000
794 DRUG ABUSE 1 0.0000
795 COMPLETED SUICIDE 1 0.0000
796 CEREBROVASCULAR ACCIDENT 2 0.0000
797 BALANCE DISORDER 1 0.0000
798 INSOMNIA 3 0.0000
799 GASTROINTESTINAL DISORDER 1 0.0000
800 ADVERSE DRUG REACTION 1 0.0000
801 SUICIDAL IDEATION 1 0.0000
802 MUSCLE SPASMS 2 0.0000
803 ADVERSE EVENT 1 0.0000
804 CARDIAC DISORDER 1 0.0000
805 MIGRAINE 1 0.0000
806 SOMNOLENCE 2 0.0000
807 CHEST DISCOMFORT 1 0.0000
808 SINUSITIS 1 0.0000
809 CONSTIPATION 2 0.0000
810 DISEASE PROGRESSION 1 0.0000
811 JOINT SWELLING 1 0.0000
812 WEIGHT DECREASED 2 0.0000
813 PRODUCT DOSE OMISSION ISSUE 2 0.0000
814 CONFUSIONAL STATE 1 0.0000
815 ABDOMINAL DISCOMFORT 1 0.0000
816 TOXICITY TO VARIOUS AGENTS 1 0.0000
817 MYOCARDIAL INFARCTION 1 0.0000
818 BLOOD GLUCOSE INCREASED 1 0.0000
819 OVERDOSE 1 0.0000
820 WEIGHT INCREASED 1 0.0000